Cornerstone Research’s Post

View organization page for Cornerstone Research, graphic

27,265 followers

With antitrust regulators, including the U.S. Department of Justice and Federal Trade Commission, signaling a more expansive scrutiny of mergers, the impact of pharmaceutical mergers & acquisitions on innovation remains a key point of discussion. Authors Penka Kovacheva, Maria Salgado, Anca Cojoc, and Lorenzo Cattivelli examine existing academic literature on the topic and identify remaining gaps. Read more: https://lnkd.in/ed_7F3BR This article was originally published in Concurrences in July 2024.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics